Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK)

11 filings reported holding VTAK - Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar as of Q1 2025.
Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 588,048 shares of 22,457,615 outstanding shares and own 2.62% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (250,965 shares), Warberg Asset Management LLC (180,100 shares), GEODE CAPITAL MANAGEMENT, LLC (54,213 shares), XTX Topco Ltd (44,705 shares), CITADEL ADVISORS LLC (32,967 shares), TWO SIGMA SECURITIES, LLC (17,721 shares), Tower Research Capital LLC (TRC) (6,157 shares), UBS Group AG (1,000 shares), HARBOUR INVESTMENTS, INC. (152 shares), and BANK OF AMERICA CORP /DE/ (68 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.